Share
Nanoparticles with Streptokinase as Modified Thrombolytic Agents
Hayder Abed
(Author)
·
Estabraq Alwasiti
(Author)
·
Amer Tawfeeq
(Author)
·
LAP Lambert Academic Publishing
· Paperback
Nanoparticles with Streptokinase as Modified Thrombolytic Agents - Abed, Hayder ; Alwasiti, Estabraq ; Tawfeeq, Amer
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Friday, July 26 and
Friday, August 02.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Nanoparticles with Streptokinase as Modified Thrombolytic Agents"
Streptokinase as a thrombolytic agent, is a common drug in treatment of circulatory disorders such as deep vein thrombosis, stroke and heart attack. However, immunogenicity and low biological life-time of the enzyme had limited its clinical applications. The results of this work showed high activity of Streptokinase loaded nanoparticles (Streptokinase loaded Titania nanoparticles, Streptokinase loaded fabricated magnetic nanoparticles supported with basil extraction and Streptokinase loaded fabricated magnetic nanoparticles supported with tannic acid as thrombolytic agent. In addition results showed activity of α-hemitate nanoparticles and basilextraction as thrombolytic agent for thrombus lysi
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
